Official Publications TME Pharma N.V.

Equities

Market Closed - Euronext Paris Other stock markets 16:35:15 31/05/2024 BST			5-day change	1st Jan Change
0.258 ^EUR	+3.41%		+3.20%	+12.17%

04-25	TME Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-23	TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer	CI

Extraordinary general shareholder meeting	15/05/22	CO
Extraordinary general shareholder meeting	15/05/22	CO
Extraordinary general shareholder meeting	15/05/22	CO
Annual Report	21/04/22	CO
Annual results	21/04/22	CO
Annual results	21/04/22	CO
Annual results	21/04/22	CO
Minutes of the general assembly	14/12/21	CO
Minutes of the general assembly	14/12/21	CO
Minutes of the general assembly	14/12/21	CO
Half-year report	21/10/21	CO
1st-half-year results	21/10/21	CO
1st-half-year results	21/10/21	CO
1st-half-year results	21/10/21	CO
Changes in management and corporate officers	23/06/21	CO
Changes in management and corporate officers	23/06/21	CO
Changes in management and corporate officers	23/06/21	CO
Changes in management and corporate officers	07/02/21	CO
Changes in management and corporate officers	07/02/21	CO
Changes in management and corporate officers	07/02/21	CO
Changes in management and corporate officers	31/01/21	CO
Changes in management and corporate officers	31/01/21	CO
Changes in management and corporate officers	31/01/21	CO
Admission of new securities	25/01/21	CO
Admission of new securities	25/01/21	CO